HK Pharmaceuticals™ is a drug discovery company that has developed a proprietary high definition protein discovery and characterization technology. The Company’s approach is the first to exploit the proteome’s chemical and structural diversity to separate and characterize proteins.
The result is drug development and optimization that starts with greater knowledge of the target. In addition to target discovery and drug development, the Company will use its technology to identify and decrease toxic side effects of existing drugs and pre-clinical candidates in collaboration with other pharmaceutical companies.
HK Pharmaceuticals is the fourth biotech company founded by Dr. Hubert Köster, and is managed by a team of highly experienced scientists and managers with a proven track record in publicly traded and privately held biotech companies.